



















Department of Animal Sciences 
The Ohio State University
 1
Abstract 
Vitamin C is a multifunctional antioxidant that is sequestered within the corpus luteum 
(CL). The concentrations of vitamin C found in the functional CL are 50-100 fold greater than 
concentrations in systemic plasma. Vitamin C may play a protective antioxidant role in the CL 
and has been shown to prevent apoptosis. The loss of vitamin C from the CL has been associated 
with luteolysis. Two sodium dependent vitamin C transporters (SVCT1 and SVCT2) have been 
described in various species, and the primary sequences of these proteins are known (e.g., human, 
pig, guinea pig, rats, mice). The primary sequences for SVCT1 and SVCT2 have not yet been 
reported in the sheep. Vitamin C transporters are highly conserved, and it is likely that the sheep 
CL expresses similar transport proteins. Since these transport proteins would represent critical 
elements in the regulation of vitamin C concentrations in the CL, the objective of the current 
work was to determine the primary protein sequences for SVCT1 and SVCT2 in the sheep. CL 
were surgically collected from regularly cycling sheep on day 3 of the estrous cycle. Luteal 
tissue was immediately snap frozen in liquid nitrogen and stored at -80° C. RNA was extracted 
from CL and transcribed into cDNA using MMLV reverse transcriptase. PCR was then run using 
primers that were designed from known SVCT sequences. PCR-amplified cDNA fragments of 
the predicted lengths were resolved by agarose electrophoresis, excised, and cloned into plasmids. 
Plasmids were transformed into Escherichia coli for amplification prior to DNA sequence 
analyses. We have sequenced a 296 base pair portion of the message for ovine SVCT1 and an 
1860 base pair portion of the message for ovine SVCT2. This encodes for 98 amino acids for 
oSVCT1 and 618 amino acids plus the stop codon for oSVCT2. The length of the oSVCT1 
amino acid sequence corresponds to 14% of the presumptive sequence based upon that of the 
human. We have found the sheep message to have high homology with that of the human (93%), 
the pig (92%), the rat (90%), and mouse (90%). The protein sequence was also found to have 
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high homology with that of the human (100%), the pig (98%), the rat (100%), and mouse (98%). 
The length of the oSVCT2 amino acid sequence corresponds to 95% of the presumptive 
sequence based upon that of the human. We have found the sheep message to have high 
homology with that of the human (90%), the pig (93%), the rat (87%), and the mouse (87%). The 
protein sequence was also found to have high homology with that of the human (89%), the pig 
(88%), the rat (86%), and mouse (86%). These data are important in furthering studies of the 
regulation of SVCT proteins and vitamin C concentrations in the CL of the sheep. 
 
Introduction 
The functional corpus luteum (CL) is an ovarian structure that produces progesterone and 
is important for the maintenance of pregnancy in the sheep. The CL, along with several other 
tissues such as the adrenal glands, brain, and pituitary, is known to have high concentrations of 
L-ascorbic acid, vitamin C (Szent-Györgyi, 1928; Glick and Biskind, 1935a; Glick and Biskind, 
1935b; Biskind and Glick, 1936; Levine and Morita, 1985; Petroff et al., 1997). The 
concentration of vitamin C in the CL is the highest in the body, with the exception of the adrenal 
glands and pituitary, and is hormonally regulated (Paeschke, 1970 [cited in Pepperell et al., 
2003]; Levine and Morita, 1985; Musicki et al., 1996; Petroff et al., 1997). The vitamin C 
content in the CL is at its maximum when the CL is fully mature, remains high during pregnancy, 
and decreases as the CL regresses (Biskind and Glick, 1936; Hoch-Ligeti and Bourne, 1948; 
Petroff et al., 1997). 
In the absence of pregnancy in the sheep, luteal regression begins on day fourteen after 
estrus and continues through days sixteen and seventeen (Rothchild, 1981; Hoyer, 1998). Uterine 
prostaglandin-F2α (PGF2α) is the luteolytic signal in ruminants and other mammals (Rothchild, 
1981; Horton and Poyser, 1976; Behrman et al., 1993; Niswender and Nett, 1994; Niswender et 
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al., 2000). PGF2α can shorten the estrous cycle or end pregnancy by inducing luteolysis (i.e., 
regression of the CL), thus ending the supply of progesterone. The decrease in progesterone 
precedes structural luteolysis and is followed by the loss of luteal weight around twenty-four 
hours after exposure to PGF2α (Christenson et al., 1995; Hoyer, 1998). In a young CL, in the case 
of sheep prior to days three through five of the estrous cycle, PGF2α has a transient effect 
(Rothchild, 1981; Pope and Cárdenas, 2004). There have been several proposed mechanisms to 
explain the luteolytic effect of PGF2α: a rapid decrease in luteal blood flow, a reduced number of 
luteinizing hormone receptors, an uncoupling of luteinizing hormone receptors from adenylate 
cyclase, the activation of protein kinase C, an influx of calcium, generation of oxidative radicals, 
and a cytotoxic effect (Horton and Poyser, 1976; Behrman et al., 1993; Niswender and Nett, 
1994; Tilly, 1996; Niswender et al., 2000). These events have been shown to occur in response to 
PGF2α, but it is important to consider their sequence and to determine which events are 
consequences of others.  
In the CL, oxidative radicals cause lipid peroxidation, decreased membrane fluidity, 
calcium influx, desensitization of the luteinizing hormone-receptor complexes, loss of 
steroidogenesis, inhibition of RNA synthesis, and RNA and genomic degradation; all of these 
events are consistent with apoptosis, programmed cell death, thus suggesting that oxidative 
radicals may be fundamental in the initiation of luteolysis and therefore inhibition of 
progesterone synthesis (Sawada and Carlson, 1985; Behrman et al., 1989; Sawada and Carlson, 
1989; Margolin et al., 1990; Riley and Behrman, 1991; Sawada and Carlson, 1991; Aten et al., 
1992; Behrman et al., 1993; Carlson et al., 1993; Musicki et al., 1994; Sawada and Carlson, 1994; 
McConkey and Orrenius, 1996; Tilly, 1996; Kato et al., 1997; Dharmarajan et al., 1999; 
Niswender et al., 2000; Tanaka et al., 2000; Pepperell et al., 2003). There are several 
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mechanisms by which cells protect themselves from oxidative radicals, including antioxidant 
vitamins, such as vitamin C (Biskind and Glick, 1936; Aten et al., 1992, Behrman et al., 1993; 
Kato et al., 1997; Tanaka et al., 2000). Vitamin C, in the forms of L-ascorbic acid and 
semidehydroascorbic acid, the free radical form, reduce oxidative radicals by donating one 
electron and in the process are converted to semidehydroascorbic acid or dehydroascorbic acid, 
respectively (Szent-Györgyi, 1928; Sawyer et al., 1982; Winkler et al., 1994; Levine and Morita, 
1985; Bendich et al., 1986; Niki, 1991; Rose and Bode, 1993). Vitamin C is especially important 
biologically, because one molecule can deactivate more than 2.5 superoxide ions and its one-
electron reduction potential is lower than many other antioxidants (Sawyer et al., 1982; Rose and 
Bode, 1993). Both vitamin C and vitamin E have been shown to suppress apoptosis (Vierk et al., 
1988; Tilly and Tilly, 1995; McConkey and Orrenius, 1996; Dharmarajan et al., 1999). Vitamin 
E, which vitamin C can reduce, thereby restoring its antioxidant properties, is the only lipid 
soluble antioxidant. This feature makes Vitamin E especially important in the reduction of 
oxidative radicals in hydrophobic areas (Golumbic and Mattill, 1941; Chen et al.,, 1980; Packer 
et al., 1979; Bendich et al., 1986; Niki, 1987; Niki, 1991; Winkler et al., 1994). Besides 
generating oxidative radicals, PGF2α stimulates vitamin C depletion. This is due to stimulation of 
cellular secretion and by inhibition of vitamin C uptake (Stansfield and Flint, 1967; Fomichev, 
1971 [cited in Pepperell 2003]; Sato et al., 1974; Levine and Morita, 1985; Aten et al., 1992; 
Musicki et al., 1996; Petroff et al., 1998; Tsai and Wiltbank, 1998). In pigs, treatment of CL with 
PGF2α increased the concentrations of vitamin C in the veins draining the ovary within fifteen 
minutes (Petroff et al., 1998). More than fifty-percent of the vitamin C depletion occurs in the 
first 2.5 minutes with the depletion remaining for up to two hours (Musicki et al., 1996). This 
suggests that vitamin C efflux is one of the earliest events in luteolysis, as an increase in 
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apoptosis does not occur until progesterone concentrations decrease (Juengel et al., 1993). CL 
that are exposed to PGF2α prior to day 3 of the ovine estrous cycle remain functional and regain 
vitamin C, whereas CL that are exposed to PGF2α on day 10 do not regain the vitamin C that is 
lost and ultimately regress (Gaddis and Ottobre, unpublished data). In the CL, concentrations of 
vitamin C increase as the CL ages; vitamin C concentrations rise from around 440 µg/g in the 
day 3 CL to around 670 µg/g in the day 10 CL (Gaddis and Ottobre, unpublished data). 
Vitamin C is transported into many tissues, including the CL, via an energy- and sodium- 
dependent process carried out by two sodium-dependent vitamin C transporters: SVCT1 and 
SVCT2 (Tsukaguchi et al., 1999). Portions of SVCT1 have been sequenced in the human, pig, 
rat, mouse, and guinea pig, while portions of SVCT2 have been sequenced in the dog and rabbit, 
in addition to the species mentioned for SVCT1. Northern-Blot analysis shows that ovarian 
tissue has large amounts of SVCT1 and SVCT2 mRNA, thus suggesting that these transport 
proteins are important in maintaining the large amounts of vitamin C found in the CL (Wang et 
al., 1999). SVCT2 is widely distributed with a 7.5 kb transcript detected in most tissues, except 
lung and skeletal muscle (Rajan et al., 1999; Tsukaguchi et al., 1999; Wang et al., 2000; Clark et 
al., 2002). SVCT1 is highly expressed in kidney, liver, small intestine, colon, prostate, and ovary 
with approximately 2.4 – 3 kb transcript; this corresponds with tissues that have large quantities 
of Vitamin C (Tsukaguchi et al., 1999; Wang et al., 1999, Wang et al., 2000). SVCT1, the 
primary role of which appears to be in the absorption of dietary Vitamin C, has a higher Vmax 
than SVCT2, resulting in a higher influx of vitamin C (Tsukaguchi et al., 1999; Liang et al., 2001; 
Takanaga et al., 2004). We suspect that the level of expression of the SVCT1 and SVCT2 genes 
in the CL may change as concentrations of Vitamin C change during luteal development and 
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regression. We also suspect that treatment with PGF2α may result in divergent effects on the 
expression of SVCT1 and SVCT2 that depend on the age of the CL at the time of treatment. 
As mentioned above, the primary sequences for SVCT1 and SVCT2 have not yet been 
reported in the sheep. Vitamin C transporters are highly conserved, and it is likely that the sheep 
CL expresses similar transport proteins. Since these transport proteins would represent critical 
elements in the regulation of vitamin C concentrations in the CL, the objective of the current 
work was to determine portions of the nucleotide sequences for SVCT1 and SVCT2 in the sheep. 
Materials & Methods 
Experimental model and collection of previously obtained CL: 
Commercial ewes (n = 22) were used in this study. The onset of estrus (day 0) was 
determined by twice daily observation in the presence of a vasectomized ram. Surgical 
procedures were performed on day 3 (early luteal phase) or day 10 (mid luteal phase). Intact 
ewes received intramuscular injections of 25mg of PGF2α (Lutalyse; Pharmacia & Upjohn, 
Kalamazoo, MI) or vehicle on day 3, a time when CL are insensitive to the luteolytic effects of 
PGF2α or day 10, a time when CL are sensitive to the luteolytic effects of PGF2α. Ewes were 
randomly assigned to one of four groups: early luteal phase control (n = 5), early luteal phase 
PGF2α-treated (n = 7), mid luteal phase control (n = 5), and mid luteal phase PGF2α-treated (n = 
5). On day 3 or 10 of the estrous cycle, depending on the experimental group, ewes were 
transported to the surgical facility (Figure 1). Prior to the first surgery, one jugular vein was 
catheterized using a 14 g x 5.5” i.v. catheter (Abboth Ireland, Republic of Ireland). Ewes were 
sedated using intravenous Pentothal (Abbott Laboratories, North Chicago, IL) in order to 
intubate them using an Aire-Cuf veterinary endotracheal tube (i.d. 10 mm, o.d. 14.3 mm; Bivona 
Inc., Gary, IN). A surgical plane of anesthesia was maintained throughout the experiment using 
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halothane gas. A midventral laparotomy was performed to expose the reproductive tract. Each 
ewe received an intramuscular injection of either 25mg of PGF2α or saline (time 0). One CL was 
removed at 2 hours post-treatment. At twenty-four hours post-treatment, a surgical plane of 
anesthesia was established and the remaining CL were removed.  
 
  recovery 
 d 0 (estrus)      d 3 or 10    d 4 or 11 
 Day of cycle 
           Surgery to remove 2nd CL 
      Surgery 
          -PGF2α or saline treatment 
          -Remove 1 CL 2 hours post treatment 
 
Figure 1. Experimental Protocol for Control and PGF2α Treated Ewes 
 
Luteal tissues were immediately dissected into three portions and snap frozen in liquid 
nitrogen. The samples were stored at -80°C. One portion was used to measure progesterone 
concentrations, and another to measure vitamin C concentrations which was used for the Gaddis 
and Ottobre (unpublished data). The third portion of the CL was used for RNA isolation and 
gene sequencing. (This portion of materials and methods was adapted from Gaddis and Ottobre 
unpublished data). 
RNA isolation and gene sequencing: 
The RNA was isolated from a day 3 control CL using RNAqueous®-4PCR Kit (Ambion 
Inc., Austin, TX). Total RNA was then reverse transcribed with RETROscript® Kit (Ambion Inc., 
Austin, TX), which utilizes the MMLV reverse transcriptase to create the cDNA. The cDNA 
generated was then run in a series of polymerase chain reactions (PCR). A variety of primers and 
conditions were used in order to amplify PCR targets. Modifications for PCR included varying 
thermal cycling conditions, concentration of Taq DNA polymerase, and running PCR on PCR 
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product cDNA excised from agarose gel. Herculase® Enhanced DNA polymerase (Stratagene, La 
Jolla, CA) was utilized in all PCR reactions.  
PCR primer design: 
Two sets of overlapping primers were used to isolate SVCT2 fragments: 5’ 
CTTTACTCTTCCGGTGGTG 3’ (forward) & 5’ ATGCCATCGAGAACACAGG 3’ (reverse), 
and 5’ GTCTATCGGGGACTACTACGCC 3’ (forward) & 5’ GGCTATACTGTGGCCTGGG 
3’ (reverse). These sets of primers were anticipated to yield 1196 base pair and 776 base pair 
fragments respectively. The primers were similar to those used by Clark et al. (2002), in the 
guinea pig, and Gispert et al. (2000), in the mouse. The primers 5’ 
GTCTATCGGGGACTACTACGCC 3’ (forward) & 5’ ATGCCATCGAGAACACAGG 3’ 
(reverse) also were used to amplified the 114 base pair overlap. 
 
Table 1. GenBank reference numbers for sequences of SVCT1 and SVCT2 used to design PCR 
primers for the respective sequences in the sheep. 
 
The SVCT1 primers, 5’ CACTGGAGAGATGGAAATGCC 3’ (forward) & 5’ 
GATCAGGAGAATGGAGCAAGC 3’ (reverse) were designed to be one-hundred percent 
homologous to the pig sequence AY353718 and were expected to yield a 296 base pair fragment. 
This was because the SVCT2 sequence was most similar to the pig. Primers were manufactured 
by Invitrogen (Carlsbad, CA). 
 
 
Sodium Dependent Vitamin C Transporter Sequences 
 
Homo 











SVCT1 AF170911 AY353718 AF080452 BC013528 AF410935   
SVCT2 AJ269478 AF058320 AF080453 AY004874 AF411585 AY264779 AF118561
 9
Polymerase Chain Reaction: 
All SVCT2 primer combinations that were reported to work required PCR conditions of 1 
minute at 94º C, 2 minutes at 55º C, and 3 minutes at 68º C. SVCT1 required PCR conditions of 
1 minute at 94º C, 2 minutes at 60º C, and 3 minutes at 72º C with a reduced amount of Taq 
DNA polymerase. 
Cloning and Sequencing: 
Following PCR, the product was run on an agarose gel and bands were visualized using 
UV light following staining with ethidium bromide. cDNA from bands corresponding to the 
expected sizes was then extracted using QIAquick Gel Extraction® (Qiagen, Valencia, CA). For 
SVCT2 the gel extract was used for cloning, but for SVCT1, the sample was re-run under 
identical PCR conditions and the PCR product was cloned. The product was then cloned into 
Escherichia coli using TOPO TA Cloning® Kit For Sequencing (Invitrogen, Carlsbad, CA). The 
plasmids were then purified using Qiagen Midi Plasmid Prep Kit (Qiagen, Valencia, CA). The 
plasmids were then sent to Genotyping Sequencing Unit in the Comprehensive Cancer Center at 
The Ohio State University for sequence analysis.  
Sequencing and data analysis: 
Plasmid samples were sequenced using the M13 forward and reverse primers. BigDye 
sequencing chemistry was used on an ABI3700 and performed by the Genotyping Sequencing 
Shared Resource at The Ohio State University. Sequence identity was confirmed by Basic Local 
Alignment Search Tool (BLAST) utilizing programs provided by the National Center for 
Biotechnology Information (http://www.ncbi.nlm.nih.gov/BLAST/) (Altschul et al., 1997). DNA 
sequence was translated into protein sequence using the Translate tool provided by Expert 
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Protein Analysis System (ExPASy) Proteomics Server (http://us.expasy.org/). Hydropathy 
analysis was performed using the WinPep 3.01 program.  
Results 
We have sequenced a 296 base pair portion of the message for ovine SVCT1 and an 1860 
base pair portion of the message for ovine SVCT2. The first sequence encodes for 98 amino 
acids for oSVCT1 acids and the second encodes for 618 amino acids plus the stop codon for 
oSVCT2 (Figure 2). The length of the oSVCT1 sequence corresponds to 14% of the presumptive 
sequence and the oSVCT2 sequence corresponds to 95% of the presumptive sequence based 
upon that of the human. When compared to the amino acid sequence for SVCT2 in Tsukaguchi 
et al. (1999), the oSVCT2 sequence contains the first methionine as well as additional five-prime 
sequence. The oSVCT2 sequence contains all twelve putative membrane spanning regions. 















98 Amino Acids 
______________________________________________________________________________ 

















































618 Amino Acids 
Figure 2. DNA and Protein sequence of SVCT1 and SVCT2 from the sheep. Putative membrane 
spanning regions, based upon those found in Tsukaguchi et al. (1999), are underlined in the 
amino acid sequence. The oSVCT1 sequence spans from the last amino acid in putative 
membrane spanning region 3 and continues to putative membrane spanning region 5. The 
oSVCT2 sequence contains all twelve putative membrane spanning regions.  
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The SVCT sequences appear to be highly conserved and have high homology when 
compared to all currently known sequences (Tables 2 and 3). The SVCT2 homology 
comparisons are more accurate than the SVCT1 due to the larger number of nucleotides/amino 
acids that have been sequenced. The sequences are also highly conserved when compared to 
each other. The high level of homology of oSVCT1 with other species is related to the fact that 
primers were designed from regions of high homology, and the length of the sequence that we 
determined is limited. The SVCT2 sequence from the guinea pig is also limited, which may 













Tables 2 & 3. Comparisons of the ovine SVCT1 and SVCT2 nucleotide and amino acid 
sequences across species.  
 
The hydropathy analysis confirms the presence of twelve putative membrane domains 
(Figure 3). This provides further evidence that the sequences we have cloned are bona fide 
SVCT1 and SVCT2 sequences. The hydropathy analysis confirms that the proteins encoded by 




   Ovine Sodium Dependent Vitamin C Transporter Comparisons Nucleotide 
 Human Pig Rat Mouse Guinea Pig Dog Rabbit 
Sheep - opposite 
SVCT sequence 
SVCT1 93% 92% 90% 90% 91%   73% 
SVCT2 90% 93% 87% 87% 92% 93% 89% 73% 
Ovine Sodium Dependent Vitamin C Transporter Comparisons Amino Acid 
 Human Pig Rat Mouse Guinea Pig Dog Rabbit 
Sheep - opposite 
SVCT sequence 
SVCT1 100% 98% 100% 98% 100%   63% 











































Figure 3. Kyte-Doolittle hydrophobicity plots of oSVCT1 (top) and oSVCT2 (bottom) amino 
acid sequences. These plots were generated using a 21-amino-acid window. The hydrophobicity 
threshold for transmembrane helices was set at 1.15. Bars above the hydrophobicity peaks 
represent the putative transmembrane regions. Note the presence of twelve putative membrane 
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Mean Hydropathy (GRAVY) = 0.496
Scale: Kyte and Doolittle (1982)
W = 21
Hydropathy threshold for helices =  1.15
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Scale: Kyte and Doolittle (1982)
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Hydropathy Plot for SVCT2 Sequence 
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Other sequences obtained: 
The primers that were designed to amplify SVCT sequences were not specific for the 
target sequence. As a result, other sequences were amplified during PCR. Several of these 





















































186 base pairs 
______________________________________________________________________________ 
Figure 4. Other sheep sequences that were obtained through attempts to clone SVCT1 and 
SVCT2. Primers used are underlined. 4A and 4C were the only sequences to be cloned from a 
PCR product that was excised from a gel. All others were cloned when PCR product was added 
directly to the ligation reaction. 4C was the only PCR amplification that was sequenced from 
SVCT2 PCR reactions. Also note that the primer for 4A, 5’ CGGCTGCCCACCTTGG 3’which 
was supposed to be a reverse primer, as can be seen in 4D and 4E, was used as both the forward 
and reverse primer for this sequence.  
Figures 4A, 4D, and 4E represent sequences obtained from primers that failed to amplify 
SVCT1. The primers 5’ TACCTGACATGCTTCAGTGG 3’ (forward) & 5’ 
CGGCTGCCCACCTTGG 3’ (reverse), which were based upon those used by Clark et al. (2002), 
were expected to yield a 1036 base pair sequence. For 4C and 4D there were thirty cycles of 1 
minute at 94º C, 2 minutes at 60º C, and 3 minutes at 68º C to obtain a band of about 1300 base 
pairs. This band was then excised using Qiagen Midi Plasmid Prep Kit (Qiagen, Valencia, CA); 
4A was the resulting sequence after subcloning. The gel extraction was then run in PCR 
conditions of 1 minute at 94º C, 2 minutes at 60º C, and 3 minutes at 72º C to obtain a band 
around 1000 base pairs. This band was then excised using Qiagen Midi Plasmid Prep Kit 
(Qiagen, Valencia, CA) and run in PCR conditions of 1 minute at 94º C, 2 minutes at 60º C, and 
3 minutes at 72º C. The PCR product was directly subcloned; 4C and 4D were the resulting 
products. 4B was cloned in the subcloning reaction along with oSVCT1. 4A, 4B, 4D, and 4E 
were subcloned using TOPO TA Cloning® Kit For Sequencing (Invitrogen, Carlsbad, CA). 4C 
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was an extra PCR product that SVCT2 primers amplified. This PCR product utilized the same 
PCR conditions as the SVCT2 primers. It was also excised from the gel utilizing Qiagen Midi 
Plasmid Prep Kit (Qiagen, Valencia, CA) and subcloned using TOPO TA Cloning® Kit PCR® 
2.1–TOPO® Vector (Invitrogen, Carlsbad, CA). 4C appears to be α-2 type IV collagen (COL4A2) 
mRNA based upon BLAST results (Altschul et al., 1997). 
Discussion 
PGF2α causes luteal regression of the CL; the mechanisms by which it causes this have 
not been fully elucidated. The unpublished data from Gaddis and Ottobre show that PGF2α causes 
an immediate decrease in progesterone synthesis in the mid-luteal phase CL, but not in the early-


















Figure 5. Concentrations of progesterone in peripheral plasma of contemporary intact sheep. 
PGF2α (25mg) was administered intramuscularly on day 3 or 10 (n=7 ewes/grp). Jugular venous 
samples were obtained daily beginning on the day of injection and continuing for one week or 
the onset of estrus, whichever occurred first. Data represent means (+SE). Figure from Gaddis 
and Ottobre unpublished data. 
 
Figure 5 shows this change in progesterone concentration in the peripheral plasma while 
figure 6 shows this change in the tissue. Progesterone concentrations in CL from the early-luteal 
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Day of Estrous Cycle
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phase were similar at both two and twenty-four hours for PGF2α treated tissues. In the tissues 
from the mid-luteal phase PGF2α-treated sheep, progesterone concentrations at two hours were 


































Figure 6. Progesterone concentrations (least squares mean + SE) in corpora lutea as a function of 
day of cycle, PGF2α treatment, and interval from injection to CL removal. Ewes were injected 
intramuscularly with PGF2α (25mg) or saline on Day 3 or Day 10 of the estrous cycle. Corpora 
lutea were collected 2h and 24h after treatment. Bars with uncommon letters are significantly 
different (p<0.05, n=5-7/grp). Figure from Gaddis and Ottobre unpublished data. 
 
The Gaddis and Ottobre unpublished data also showed the change in vitamin C 
concentrations in relation to the day of the cycle and to treatment with PGF2α. This is important 
because vitamin C is known to be important in fertility and it has been speculated that it may 
enhance fertility and cure some types of infertility (Kramer et al., 1933; Phillips et al., 1941; Pye 
et al., 1961; Luck et al., 1995; Dabrowski and Ciereszko, 2001). Figure 7 shows how the 
concentration of vitamin C increases between days three and ten. Figure 7 also shows how PGF2α 
causes a loss of vitamin C in both the early and mid luteal phase CL, but that it is regained in the 




















Figure 7. Ascorbate concentrations (least squares mean + SE) in corpora lutea as a function of 
day of cycle, PGF2α treatment, and interval from injection to CL removal. Ewes were injected 
intramuscularly with PGF2α (25mg) or saline on Day 3 or Day 10 of the estrous cycle. Corpora 
lutea were collected 2h and 24h after treatment. Bars with uncommon letters are significantly 
different (p<0.05, n=5-7/grp). 
 
 This change in ability of the CL to regain vitamin C also coincides with the resistance of 
the CL to PGF2α. This was also confirmed in the Gaddis and Ottobre unpublished data by 
measuring the time required for the sheep to show estrus. The early-luteal phase CL remained 
functional and the sheep did not experience estrus for about fifteen more days, while the mid-
luteal phase sheep experienced estrus within about two days when treated with PGF2α (Table 4).  
_____________________________________________________________________________ 
Treatment group Day 3 Day 10 
 
Average interval from 
PGF2α to estrus (days) 
 
 
14.71 + 0.21 
 
2.07 + 0.07 
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b
a,e
















These data from Gaddis and Ottobre show that vitamin C can rapidly enter and leave the 
CL. The sodium dependent vitamin C transporters SVCT1 and SVCT2 are likely involved in 
actively transporting vitamin C into the luteal cells. A likely mechanism that contributes to 
changes in luteal concentrations of vitamin C during different stages of the estrous cycle is 
changes in the production of SVCT proteins. In addition, PGF2α may interfere with the ability of 
SVCT proteins to transport vitamin C. Because of this, the vitamin C is lost from the tissue and 
antioxidants are allowed to cause damage. The early-luteal phase CL is likely expressing the 
genes for SVCT, which allows the transporters to be rapidly replaced, thereby resulting in re-
accumulation of vitamin C. If the SVCT genes are not expressed in the mid-luteal phase, which 
would be possible if the proteins are stable and have a long half-life, then the vitamin C would 
not be reabsorbed. This scenario does not sufficiently explain the rapid loss of vitamin C from 
luteal tissue; however, this mechanism has not yet been described (Friedman and Zeidel, 1999; 
Hediger, 2002; Takanaga et al., 2004). 
Another important consideration, based on data in the human (Lutsenko et al., 2004), is 
that there may be an SVCT2 isoform in the sheep that acts as a dominant-negative inhibitor of 
vitamin C transport. If this mechanism is also present in the sheep, then it could explain the 
inability of mid-luteal phase CL from PGF2α-treated sheep to reabsorb vitamin C. Our PCR 
results did not show a band corresponding to the short isoform of SVCT2. This would have been 
an approximately 870 base pair PCR product along with the 1196 base pair PCR product. 
Because PCR was performed on only a day 3 CL, the short isoform may be at a minimum 
concentration and therefore unobservable. 
Other studies have shown that genes regulating progesterone synthesis and susceptibility 
to PGF2α are regulated at the transcription level throughout the lifespan of the CL. The mRNA 
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for steroidogenic acute regulatory protein, which regulates progesterone synthesis, has been 
shown to decrease within four hours of injection of PGF2α. Concentrations of this message, reach 
a minimum of 36% of normal levels at twelve hours, and continue to be decreased for twenty-
four hours (Juengel et al., 1995; Stocco and Clark, 1996; Niswender et al., 2000; Diaz et al., 
2002). Results of studies that examined PGF2α receptor mRNA expression varied; three studies 
reported consistent expression between days three, four, six, nine, ten, twelve, and fifteen (Wiepz 
et al., 1992; Juengel et al., 1996; Juengel et al., 1998), while two ovine studies and a bovine 
study using “real-time” PCR reported a decrease in mRNA expression between days ten and 
sixteen (Graves et al., 1995; Rueda et al., 1995a; Arosh et al., 2004); all studies agree that PGF2α 
decreases PGF2α receptor mRNA. Levels of 15-hydroxyprostaglandin dehydrogenase, which 
catalyzes the rate-limiting step in PGF2α inactivation, similarly decreased from 301 ± 47 amol/µg 
poly(A)+ RNA on day four to 17 ± 5 amol/µg poly(A)+ RNA on day thirteen of the ovine estrous 
cycle (Silva et al., 2000). The mRNAs for protein kinase C inhibitor-1 and kinase C inhibitor 
protein-1, which inhibit protein kinase C, the secondary messenger system for PGF2α, have a 
higher concentration on day four than days ten and fifteen and are not affected by PGF2α (Juengel 
et al., 1998). The mRNAs of superoxide dismutase, both the secreted and mitochondrial forms, 
were significantly depleted in regressing CL as compared to the functional CL (Rueda et al., 
1995b). Based upon these studies, it appears that progesterone synthesizing enzymes and PGF2α 
receptor mRNA are highly expressed only in the functional CL. PGF2α can bind to the CL at any 
time, however PGF2α and its second messenger system are rapidly inactivated prior to day four.  
Based upon these numerous studies showing that genes involved in regulating the estrous 
cycle are regulated at the transcription level, we hypothesize that SVCT1 and SVCT2 will also 
be regulated at the transcription level. This is both due to the importance of vitamin C in the CL 
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and the way vitamin C concentrations change depending on the functionality of the CL. Because 
superoxide dismutase expression is significantly higher in the functional CL, in order to protect it 
from oxidative radicals, it could be likewise expected that other antioxidant regulating genes are 
also expressed at higher levels during times of maximal CL function (Rueda et al., 1995b). 
Likewise, during luteal regression, changes in the expression of vitamin C transporters could 
favor loss of vitamin C from the tissue and render the CL more susceptible to oxidative damage. 
The current data defining ovine sequences for vitamin C transporters are important in furthering 
studies of the regulation of SVCT proteins and vitamin C concentrations in the CL of the sheep. 
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